Cargando…
An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform‐Like Purification Process
Single chain variable fragment‐IgGs (scFv‐IgG) are a class of bispecific antibodies consisting of two single chain variable fragments (scFv) that are fused to an intact IgG molecule. A common trend observed for expression of scFv‐IgGs in mammalian cell culture is a higher level of aggregates (10%–30...
Autores principales: | Andrade, Cassia, Arnold, Lindsay, Motabar, Dana, Aspelund, Matthew, Tang, Alison, Hunter, Alan, Chung, Wai Keen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667909/ https://www.ncbi.nlm.nih.gov/pubmed/30298991 http://dx.doi.org/10.1002/btpr.2720 |
Ejemplares similares
-
Characterization and analysis of scFv-IgG bispecific antibody size variants
por: Cao, Mingyan, et al.
Publicado: (2018) -
Current trends and challenges in the downstream purification of bispecific antibodies
por: Chen, Serene W, et al.
Publicado: (2021) -
HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6
por: Moshoette, Tumelo, et al.
Publicado: (2022) -
Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins
por: Surowka, Marlena, et al.
Publicado: (2021) -
Column-Free Purification Methods for Recombinant Proteins Using Self-Cleaving Aggregating Tags
por: Fan, Yamin, et al.
Publicado: (2018)